Literature DB >> 30165395

A 9-Point Risk Assessment for Patients Who Inject Drugs and Require Intravenous Antibiotics: Focusing Inpatient Resources on Patients at Greatest Risk of Ongoing Drug Use.

Ellen F Eaton1, Ronnie E Mathews1, Peter S Lane1, Cayce S Paddock1, Jorge Martin Rodriguez1, Benjamin B Taylor1, Michael S Saag1, Meredith L Kilgore1, Rachael A Lee1.   

Abstract

A 9-point risk assessment identified persons with a history of injection drug use who were safe for discharge. "Low-risk" patients were discharged with outpatient antibiotics; others continued inpatient treatment. Use of the assessment reduced the mean length of stay by 20 days and total direct cost by 33%, creating capacity for an additional 333 patients.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cost; endocarditis; hospitalization; injection drug use; length of stay; readmission

Mesh：

Substances：

Year:  2019        PMID： 30165395     DOI： 10.1093/cid/ciy722

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  16 in total

1.  Outcomes of Orthopaedic Infections in Recreational Intravenous Drug Users Requiring Long-term Antibiotic Treatment.

Authors:  Erin Stockwell; Kent Rinehart; Emily Boes; Allyson Pietrok; Angela Hewlett; Curtis Hartman; Philipp Streubel
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-06-10

2.  "They Just Assume That We're All Going to Do the Wrong Thing With It. It's Just Not True": Stakeholder Perspectives About Peripherally Inserted Central Catheters in People Who Inject Drugs.

Authors:  Yoelkys Morales; Emma Smyth; Julia Zubiago; Benjamin Bearnot; Alysse G Wurcel
Journal:  Open Forum Infect Dis       Date:  2022-10-19       Impact factor: 4.423

Review 3.  A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews.

Authors:  Honora Englander; Amy Jones; Noa Krawczyk; Alisa Patten; Timothy Roberts; P Todd Korthuis; Jennifer McNeely
Journal:  J Gen Intern Med       Date:  2022-05-09       Impact factor: 6.473

Review 4.  Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments.

Authors:  Asher Schranz; Joshua A Barocas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

5.  Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.

Authors:  Laura C Fanucchi; Sharon L Walsh; Alice C Thornton; Paul A Nuzzo; Michelle R Lofwall
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

6.  Repeat Infective Endocarditis in Persons Who Inject Drugs: "Take Another Little Piece of my Heart".

Authors:  Glen Huang; Erin W Barnes; James E Peacock
Journal:  Open Forum Infect Dis       Date:  2018-11-16       Impact factor: 3.835

Review 7.  Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases.

Authors:  Nikhil Seval; Ellen Eaton; Sandra A Springer
Journal:  Open Forum Infect Dis       Date:  2019-12-24       Impact factor: 3.835

8.  In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections.

Authors:  Ellen F Eaton; Andrew O Westfall; Brandi McClesky; Cayce S Paddock; Peter S Lane; Karen L Cropsey; Rachael A Lee
Journal:  Open Forum Infect Dis       Date:  2020-03-03       Impact factor: 3.835

Review 9.  Soft Tissue, Bone, and Joint Infections in People Who Inject Drugs.

Authors:  Carlos S Saldana; Darshali A Vyas; Alysse G Wurcel
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

10.  Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.

Authors:  Charlie Tan; Esfandiar Shojaei; Joshua Wiener; Meera Shah; Sharon Koivu; Michael Silverman
Journal:  JAMA Netw Open       Date:  2020-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.